Shanghai Junshi to redeem all RMB 200 million convertibles on July 5

By Sarah Lizee

Olympia, Wash., June 26 – Shanghai Junshi Biosciences Co., Ltd. plans to redeem all RMB 200 million of its 10.35% six-year convertible bonds on July 5, according to an announcement.

The total redemption price will be RMB 228,242,800, which reflects par plus accrued interest.

The company said it had announced May 9 to bondholders that it had applied to the local securities regulatory bureau for guidance on the listing and offering of A shares, and the application was accepted.

For bondholders who have not applied for conversion to shares in the latest conversion declaration period, the company is entitled to redeem the unconverted bonds after the declaration period.

The Shanghai-based biopharmaceutical company engages in the research, discovery and development of various biologic drug candidates in China.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.